Nitrofurantoin

CHEMBL572 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

238.2 g/mol

LogP

-0.5

Phase

4

An antibiotic specifically concentrated in the urine, making it effective for treating and preventing urinary tract infections.

Moleküler Ağırlık

238,1600 g/mol

LogP

-0,50

TPSA

121,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Bladder Cancer Benign Prostatic Hyperplasia Pain Management Chronic Kidney Disease Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1

InChI

InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+

Molecular Formula

C8H6N4O5

HBD / HBA

1 / 6

Döndürülebilir Bağlar

2

Ağır Atomlar

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An antibiotic specifically concentrated in the urine, making it effective for treating and preventing urinary tract infections.

Yes, Nitrofurantoin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL572. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 6604200. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Nitrofurantoin PillFYI'da

Yapı

Hızlı Veriler

Formül: C8H6N4O5
Eş Anlamlılar: 9

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.